Redcare Pharmacy (RDC) Stock Overview
Operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
RDC Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Redcare Pharmacy NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €46.86 |
| 52 Week High | €130.10 |
| 52 Week Low | €30.20 |
| Beta | 1.45 |
| 1 Month Change | -7.21% |
| 3 Month Change | -32.38% |
| 1 Year Change | -62.69% |
| 3 Year Change | -52.09% |
| 5 Year Change | -70.13% |
| Change since IPO | 65.00% |
Recent News & Updates
Recent updates
Take Care Before Jumping Onto Redcare Pharmacy NV (ETR:RDC) Even Though It's 26% Cheaper
Redcare Pharmacy NV ( ETR:RDC ) shareholders that were waiting for something to happen have been dealt a blow with a...Take Care Before Jumping Onto Redcare Pharmacy NV (ETR:RDC) Even Though It's 26% Cheaper
The Redcare Pharmacy NV ( ETR:RDC ) share price has fared very poorly over the last month, falling by a substantial...Analyst Estimates: Here's What Brokers Think Of Redcare Pharmacy NV (ETR:RDC) After Its Second-Quarter Report
Shareholders might have noticed that Redcare Pharmacy NV ( ETR:RDC ) filed its second-quarter result this time last...Here's Why Redcare Pharmacy (ETR:RDC) Can Afford Some Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Redcare Pharmacy NV (ETR:RDC) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Investors in Redcare Pharmacy NV ( ETR:RDC ) had a good week, as its shares rose 2.9% to close at €127 following the...Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
eRx Surge And International Expansion Poised To Elevate Revenue And Profit Margins
Rapid expansion in new markets and tech-driven efficiencies suggest future revenue growth and improved profit margins.Here's Why Redcare Pharmacy (ETR:RDC) Can Afford Some Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Is There Now An Opportunity In Redcare Pharmacy NV (ETR:RDC)?
Redcare Pharmacy NV ( ETR:RDC ), is not the largest company out there, but it received a lot of attention from a...Are Investors Undervaluing Redcare Pharmacy NV (ETR:RDC) By 26%?
Key Insights Redcare Pharmacy's estimated fair value is €201 based on 2 Stage Free Cash Flow to Equity Current share...Investors Interested In Redcare Pharmacy NV's (ETR:RDC) Revenues
When you see that almost half of the companies in the Consumer Retailing industry in Germany have price-to-sales ratios...Redcare Pharmacy (ETR:RDC) Is Carrying A Fair Bit Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Why Investors Shouldn't Be Surprised By Redcare Pharmacy NV's (ETR:RDC) P/S
When close to half the companies in the Consumer Retailing industry in Germany have price-to-sales ratios (or "P/S...Is There An Opportunity With Redcare Pharmacy NV's (ETR:RDC) 48% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Redcare Pharmacy fair value estimate is €239 Redcare...Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Why Redcare Pharmacy NV (ETR:RDC) Could Be Worth Watching
Redcare Pharmacy NV ( ETR:RDC ), might not be a large cap stock, but it saw a significant share price rise of over 20...Why We're Not Concerned About Redcare Pharmacy NV's (ETR:RDC) Share Price
When close to half the companies in the Consumer Retailing industry in Germany have price-to-sales ratios (or "P/S...Broker Revenue Forecasts For Shop Apotheke Europe N.V. (ETR:SAE) Are Surging Higher
Shop Apotheke Europe N.V. ( ETR:SAE ) shareholders will have a reason to smile today, with the analysts making...Here's Why Shop Apotheke Europe (ETR:SAE) Can Afford Some Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Shareholder Returns
| RDC | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | -0.8% | -3.3% | -1.3% |
| 1Y | -62.7% | -33.2% | -2.0% |
Return vs Industry: RDC underperformed the German Consumer Retailing industry which returned -33.2% over the past year.
Return vs Market: RDC underperformed the German Market which returned -2% over the past year.
Price Volatility
| RDC volatility | |
|---|---|
| RDC Average Weekly Movement | 11.0% |
| Consumer Retailing Industry Average Movement | 8.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in DE Market | 13.3% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: RDC's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: RDC's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 2,163 | Olaf Heinrich | www.redcare-pharmacy.com |
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023.
Redcare Pharmacy NV Fundamentals Summary
| RDC fundamental statistics | |
|---|---|
| Market cap | €942.43m |
| Earnings (TTM) | -€37.40m |
| Revenue (TTM) | €3.07b |
Is RDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RDC income statement (TTM) | |
|---|---|
| Revenue | €3.07b |
| Cost of Revenue | €2.40b |
| Gross Profit | €673.80m |
| Other Expenses | €711.20m |
| Earnings | -€37.40m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 29, 2026
| Earnings per share (EPS) | -1.86 |
| Gross Margin | 21.93% |
| Net Profit Margin | -1.22% |
| Debt/Equity Ratio | 75.8% |
How did RDC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/18 04:56 |
| End of Day Share Price | 2026/05/15 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Redcare Pharmacy NV is covered by 24 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gerhard Schwarz | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Sarah Roberts | Barclays |